Browse EV MemProt Atlas
- Frequency:
- literature support frequency.
- EVMP score:
annotation confidence score.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40
| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| PI51A | Q99755 | Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha (PIP5K1-alpha) (PtdIns(4)P-5-kinase 1 alpha) (EC 2.7.1.68) (68 kDa type I phosphatidylinositol 4-phosphate 5-kinase alpha) (Phosphatidylinositol 4-phosphate 5-kinase type I alpha) (PIP5KIalpha) | Cancer-related genesEnzymesEssential proteinsMetabolic proteinsPredicted intracellular proteins | Adhesion and uptake mediationImmune mediationMetabolism mediationReceptor-signaling mediation | 1 | 0.50 | ||||
| PIEZ2 | Q9H5I5 | Piezo-type mechanosensitive ion channel component 2 (Protein FAM38B) | Disease related genesHuman disease related genesPotential drug targetsPredicted intracellular proteinsPredicted membrane proteinsTransporters | 38 | Fusion and delivery mediation | 1 | 0.50 | |||
| PIGB | Q92521 | GPI alpha-1,2-mannosyltransferase 3 (EC 2.4.1.-) (GPI mannosyltransferase III) (GPI-MT-III) (Phosphatidylinositol-glycan biosynthesis class B protein) (PIG-B) | Disease related genesHuman disease related genesMetabolic proteinsPredicted membrane proteins | 9 | Metabolism mediation | 1 | 0.50 | |||
| PITM3 | Q9BZ71 | Membrane-associated phosphatidylinositol transfer protein 3 (Phosphatidylinositol transfer protein, membrane-associated 3) (PITPnm 3) (Pyk2 N-terminal domain-interacting receptor 1) (NIR-1) | Disease related genesHuman disease related genesPredicted intracellular proteins | Fusion and delivery mediationMetabolism mediation | 1 | 0.50 | ||||
| PK2L2 | Q9NZM6 | Polycystin-2-like protein 2 (Polycystin-2L2) (Polycystic kidney disease 2-like 2 protein) (Polycystin-L2) | Predicted intracellular proteinsPredicted membrane proteinsVoltage-gated ion channels | 6 | Fusion and delivery mediation | 1 | 0.50 | |||
| PKHN1 | Q494U1 | Pleckstrin homology domain-containing family N member 1 (PH domain-containing family N member 1) (Cardiolipin and phosphatidic acid-binding protein) | Predicted intracellular proteins | Other mediation | 1 | 0.50 | ||||
| PKN1 | Q16512 | Serine/threonine-protein kinase N1 (EC 2.7.11.13) (Protease-activated kinase 1) (PAK-1) (Protein kinase C-like 1) (Protein kinase C-like PKN) (Protein kinase PKN-alpha) (Protein-kinase C-related kinase 1) (Serine-threonine protein kinase N) | EnzymesPredicted intracellular proteins | Clinical-translation mediationImmune mediationReceptor-signaling mediation | 1 | 0.50 | ||||
| PKP1 | Q13835 | Plakophilin-1 (Band 6 protein) (B6P) | Disease related genesHuman disease related genesPlasma proteinsPredicted intracellular proteins | Adhesion and uptake mediationFusion and delivery mediation | 1 | 0.50 | ||||
| PLAK | P14923 | Junction plakoglobin (Catenin gamma) (Desmoplakin III) (Desmoplakin-3) | Cancer-related genesDisease related genesHuman disease related genesPlasma proteinsPredicted intracellular proteins | Adhesion and uptake mediationFusion and delivery mediationImmune mediationReceptor-signaling mediation | 1 | 0.50 | ||||
| PLCB4 | Q15147 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 (EC 3.1.4.11) (Phosphoinositide phospholipase C-beta-4) (Phospholipase C-beta-4) (PLC-beta-4) | Disease related genesEnzymesHuman disease related genesMetabolic proteinsPotential drug targetsPredicted intracellular proteins | Fusion and delivery mediationMetabolism mediationReceptor-signaling mediation | 1 | 0.50 | ||||
| PLD1 | Q13393 | Phospholipase D1 (PLD 1) (hPLD1) (EC 3.1.4.4) (Choline phosphatase 1) (Phosphatidylcholine-hydrolyzing phospholipase D1) | Disease related genesEnzymesHuman disease related genesMetabolic proteinsPlasma proteinsPotential drug targetsPredicted intracellular proteinsRAS pathway related proteins | Fusion and delivery mediationImmune mediationMetabolism mediationReceptor-signaling mediation | 1 | 0.50 | ||||
| PLPL9 | O60733 | 85/88 kDa calcium-independent phospholipase A2 (CaI-PLA2) (EC 3.1.1.4) (2-lysophosphatidylcholine acylhydrolase) (EC 3.1.1.5) (Group VI phospholipase A2) (GVI PLA2) (Intracellular membrane-associated calcium-independent phospholipase A2 beta) (iPLA2-beta) (Palmitoyl-CoA hydrolase) (EC 3.1.2.2) (Patatin-like phospholipase domain-containing protein 9) (PNPLA9) | Disease related genesEnzymesHuman disease related genesMetabolic proteinsPotential drug targetsPredicted intracellular proteinsPredicted membrane proteinsRAS pathway related proteins | 2 | Fusion and delivery mediationImmune mediationMetabolism mediation | 1 | 0.50 | |||
| PLPP1 | O14494 | Phospholipid phosphatase 1 (EC 3.1.3.-) (EC 3.1.3.106) (EC 3.1.3.4) (EC 3.6.1.75) (Lipid phosphate phosphohydrolase 1) (PAP2-alpha) (Phosphatidate phosphohydrolase type 2a) (Phosphatidic acid phosphatase 2a) (PAP-2a) (PAP2a) | EnzymesMetabolic proteinsPredicted membrane proteins | 6 | Fusion and delivery mediationMetabolism mediationReceptor-signaling mediation | 1 | 0.50 | |||
| PLS1 | O15162 | Phospholipid scramblase 1 (PL scramblase 1) (Ca(2+)-dependent phospholipid scramblase 1) (Erythrocyte phospholipid scramblase) (Mg(2+)-dependent nuclease) (EC 3.1.-.-) (MmTRA1b) | Predicted intracellular proteinsTransporters | 1 | Fusion and delivery mediationImmune mediationMetabolism mediation | 1 | 0.50 | |||
| PLSL | P13796 | Plastin-2 (L-plastin) (LC64P) (Lymphocyte cytosolic protein 1) (LCP-1) | Cancer-related genesDisease related genesPlasma proteinsPredicted intracellular proteins | Adhesion and uptake mediationFusion and delivery mediationImmune mediation | 1 | 0.50 | ||||
| PLXA4 | Q9HCM2 | Plexin-A4 | Predicted intracellular proteinsPredicted membrane proteins | 1 | Adhesion and uptake mediationReceptor-signaling mediation | 1 | 0.50 | |||
| POPD1 | Q8NE79 | Popeye domain-containing protein 1 (Popeye protein 1) | Disease related genesHuman disease related genesPotential drug targetsPredicted membrane proteinsTransporters | 3 | Adhesion and uptake mediationFusion and delivery mediationReceptor-signaling mediation | 1 | 0.50 | |||
| PP16B | Q96T49 | Protein phosphatase 1 regulatory inhibitor subunit 16B (Ankyrin repeat domain-containing protein 4) (CAAX box protein TIMAP) (TGF-beta-inhibited membrane-associated protein) (hTIMAP) | Predicted intracellular proteins | Receptor-signaling mediation | 1 | 0.50 | ||||
| PPAT | Q9BZG2 | Testicular acid phosphatase (EC 3.1.3.2) (Acid phosphatase 4) | 1 | Metabolism mediationReceptor-signaling mediation | 1 | 0.50 | ||||
| PPIP1 | O43586 | Proline-serine-threonine phosphatase-interacting protein 1 (PEST phosphatase-interacting protein 1) (CD2-binding protein 1) (H-PIP) | Disease related genesHuman disease related genesPredicted intracellular proteins | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.50 | ||||
| PPIP2 | Q9H939 | Proline-serine-threonine phosphatase-interacting protein 2 (PEST phosphatase-interacting protein 2) | Predicted intracellular proteins | Fusion and delivery mediation | 1 | 0.50 | ||||
| PRAX | Q9BXM0 | Periaxin | Disease related genesHuman disease related genesPlasma proteinsPredicted intracellular proteins | Fusion and delivery mediation | 1 | 0.50 | ||||
| PROM1 | O43490 | Prominin-1 (Antigen AC133) (Prominin-like protein 1) (CD antigen CD133) | CD markersDisease related genesHuman disease related genesPotential drug targetsPredicted intracellular proteinsPredicted membrane proteinsTransporters | 5 | Acute myeloid leukaemiaBrain cancerColorectal cancerLiver cancerOvarian cancerPancreatic cancerSolid tumour/cancer | Clinical-translation mediationFusion and delivery mediation | 1 | 0.50 | ||
| PROM2 | Q8N271 | Prominin-2 (PROM-2) (Prominin-like protein 2) (hPROML2) | Predicted membrane proteinsTransporters | 5 | Adhesion and uptake mediationFusion and delivery mediationReceptor-signaling mediation | 1 | 0.50 | |||
| PRR7 | Q8TB68 | Proline-rich protein 7 (Synaptic proline-rich membrane protein) | Predicted intracellular proteinsTransporters | 1 | Immune mediation | 1 | 0.50 |